Quote of the Day
"There’s a lot of luck involved in life and investing. Don’t fool yourself into thinking everything that goes right or wrong is of your own doing."
(Sam Ro)
Chart of the Day
Novo Nordisk ($NVO) and Eli Lilly ($LLY) are soaring based on favorable clinical trial results. (via @ycharts)
Strategy
- Don't make your investments based on who is in the White House. (retirementresearcher.com)
- When do dividend-focused strategies outperform? (morningstar.com)
Semiconductors
- Arm Holdings is planning investments from Apple, Samsung and Intel on its IPO. (asia.nikkei.com)
- Taiwan Semi ($TSM) is building a big chip factory in Germany. (retirementresearcher.com)
Weight loss
- In a study, Novo Nordisk’s ($NVO) Wegovy not only helped people lose weight but also reduced their risk of cardiovascular events. (biopharmadive.com)
- A large portion of the population is interested in obesity drugs, but don't want to do injectables. (nytimes.com)
- As evidence piles up, insurers will have a problem not paying for the new weight loss drugs. (bloomberg.com)
Venture capital
- Some sectors, like co-working, that turned out to be 'winner-take-none.' (hunterwalk.com)
- Chinese VCs are pulling back from the U.S. (scmp.com)
News media
- Why the media needs to be more credulous when covering Elon Musk. (platformer.news)
- Puck News just raised a new round (~$10 million) of capital. (axios.com)
Economy
- What does measures of 'economic uncertainty' actually measure? (ritholtz.com)
- Twitter's changes may wreck it as a sentiment tool. (economist.com)
- Lotteries are 'state-sponsored scams.' (whyisthisinteresting.substack.com)
Earlier on Abnormal Returns
- Research links: learning in a bear market. (abnormalreturns.com)
- What you missed in our Monday linkfest. (abnormalreturns.com)
- Adviser links: next generation investors. (abnormalreturns.com)
- Are you a financial adviser looking for some out-of-the-box thinking? Then check out our weekly e-mail newsletter. (newsletter.abnormalreturns.com)
